XRF Scientific Limited (XRF) 2013年年度报告「ASX」.pdf

1、XRF SCIENTIFIC LIMITED ABN 80 107 908 314 ANNUAL FINANCIAL REPORT FOR THE YEAR ENDED 30 JUNE 2013 For personal use onlyXRF SCIENTIFIC LIMITED|2013 ANNUAL REPORT 1CONTENTS CHAIRMANS LETTER 3 DIRECTORS REPORT 4 AUDITORS INDEPENDENCE DECLARATION 17 CORPORATE GOVERNANCE DISCLOSURE 18 CONSOLIDATED STATEM

2、ENT OF PROFIT 25 OR LOSS AND OTHER COMPREHENSIVE INCOMECONSOLIDATED STATEMENT OF 26 FINANCIAL POSITION CONSOLIDATED STATEMENT OF 27 CHANGES IN EQUITY CONSOLIDATED STATEMENT OF 28 CASH FLOWS NOTES TO THE CONSOLIDATED 29 FINANCIAL STATEMENTS DIRECTORS DECLARATION 65 AUDITORS REPORT 66 SHAREHOLDER INFO

3、RMATION 68 CORPORATE DIRECTORY 70 For personal use onlyFINANCIAL RESULTS SUMMARY 2 XRF SCIENTIFIC LIMITED|2013 ANNUAL REPORT Sales down 11%Net Profit After Tax up 7%Operating Cash Flow up 13%Earnings Per Share up 4%12,47820,06125,40822,49610111213Sales Revenue($000)3032,6353,5793,81310111213Net Prof

4、it After Tax($000)7742,5943,6624,13110111213Operating Cash Flow($000)0.32.52.82.910111213Earnings Per Share(Cents)For personal use only XRF SCIENTIFIC LIMITED|2013 ANNUAL REPORT 3 CHAIRMANS LETTER Dear Shareholder,In spite of a decrease in total revenue and other income from$25.9m in 2011-12 to$23.2

5、m in 2012-13 the Company was able to increase after tax profits from$3.58m to$3.81m.Consistent with our commitments to shareholders of maintaining shareholder returns and value,there was an increase in the fully franked dividend to 1.7 cents per share.These results reflect the implementation of your

6、 Boards strategic directions,effective marketing,products support,cost control and financial management skill by the management team.The continuation of political and financial difficulties in Europe,North America and a slowdown in China,combined with a heightened degree of political uncertainty in